NEW YORK, Dec. 17, 2014 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq:TGTX), today announced the appointment of Kenneth Hoberman to the Company's Board of Directors. Mr. Hoberman is currently the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results